Marshall Wace’s Lyra Therapeutics LYRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-259
Closed -$74K 2858
2022
Q2
$74K Buy
+259
New +$74K ﹤0.01% 2576
2021
Q4
Sell
-249
Closed -$114K 3415
2021
Q3
$114K Sell
249
-137
-35% -$62.7K ﹤0.01% 2269
2021
Q2
$155K Sell
386
-553
-59% -$222K ﹤0.01% 1977
2021
Q1
$544K Buy
939
+658
+234% +$381K ﹤0.01% 1614
2020
Q4
$160K Buy
+281
New +$160K ﹤0.01% 1629